Article info
PDFOriginal research
Construction of a reference material panel for detecting KRAS/NRAS/EGFR/BRAF/MET mutations in plasma ctDNA
- Correspondence to Ms Xiaoyan Chang, Department of Pathology, Peking Union Medical College Hospital, Beijing 100730, China; 13683662636{at}163.com; Dr Xuexi Yang, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China; yangxuexi2017{at}126.com; Dr Jie Huang, Division of Diagnostic for Non-infectious Disease, National Institutes for food and drug Control, Beijing 100050, China; jhuang5522{at}126.com
Citation
Construction of a reference material panel for detecting KRAS/NRAS/EGFR/BRAF/MET mutations in plasma ctDNA
Publication history
- Received May 22, 2020
- Revised June 28, 2020
- Accepted July 2, 2020
- First published August 17, 2020.
Online issue publication
May 31, 2021
Article Versions
- Previous version (19 April 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.